Denvax is Dendritic Cell Therapy,
-that works to boost immunity against cancer
DENVAX: DENDRITIC CELL THERAPY FOR CANCER
Dendritic cells are cells of the immune system that help in the fight against cancer.
Denvax is your personalised cancer treatment that involves cancer-fighting dendritic cells. Being autologous, it is non-toxic and does not interfere with an ongoing treatment plan or the patient’s daily routine.
Denvax is a treatment for most solid tumours, including lymphoma and multiple myeloma. It can be given at any stage of the disease. It is targeted therapy and comes under the 4th modality of cancer treatment called cancer Immunotherapy. The other three are Surgery, Radiation and Chemotherapy.
DENVAX: HOW DOES IT WORK?
In cancer, the immune system fails as cells of the immune system fail to recognise the cancer cells. The immune system doesn’t “see” tumours as foreign or dangerous, and doesn’t mount a strong attack against them.
Another reason tumours may not stimulate an immune response is that cancer cells develop ways to escape the immune system.
A dendritic cell is a specialised cell that boosts immune responses in our body, by correcting the failure to recognise the cancer cell. The activated immune system then circulates throughout the body and destroys the cancer cells.
DENVAX USES
Denvax is an Adjuvant/Additional treatment plan. It helps to fight cancer by killing the cancer cells. It works by activating the immune system against cancer. Cancer is best treated by a multi-disciplinary approach. The other treatment modalities including surgery, radiation and chemotherapy also help to kill the cancer cells. Denvax adds to this arsenal of killing cancer. It helps to improve quality of life, prolong life and give better clinical outcomes.
Denvax has little or no conflict with other treatment modalities. Being autologous (self), it is almost non-toxic and does not interfere with the patient’s ongoing treatment plan or his/her daily routine. In stage IV patients, it works as palliative therapy, which helps in giving comfort to the patient.
METHOD OF DENVAX PREPARATION
In this technique, the patient’s own blood cells are taken and transformed into dendritic cells that are trained to fight cancer cells. These dendritic cells given back to the patient initiate a fight against the disease at the cellular level and help in stopping cancer.
The first dose manufactured is given to the patient on the 10th day of blood collection. Subsequent doses are administered at 2- weeks intervals.
HOW TO BEGIN DENVAX TREATMENT?
To begin Denvax treatment, the patient or the attendant is required to contact our office, preferably nearby the patient's location. The patient is then required to send his reports and a short video, explaining or showing his/her current clinical status.
The doctor evaluates the patient's clinical condition and may or may not advise Denvax, based on Eligibility Criteria. Patients willing to take Denvax treatment are required to fill and sign an Informed Consent Form. The logistics team then works on the collection of blood drawn from the patient’s home. They assign a trained technical staff to travel to the patient’s location for blood collection.
It takes 8 days to manufacture Denvax. The patient may choose to get the Denvax dose in the comforts of their home or visit any of the Denvax clinics for receiving the dose. Trained technical staff along with Denvax dose is sent to the patient's home for administration. The technical staff leaves the patient's home only after the dose is safely received by the patient. Further doses are administered the same way.
HOW SAFE IS DENVAX?
Denvax has negligible adverse effects or toxicity as compared to chemotherapy. Being an autologous treatment it is safe and has minimal side effects. Some patients may experience fever for a day or two after taking Denvax therapy.
Denvax is Dendritic Cell Therapy,
-that works to boost immunity against cancer
DENVAX: DENDRITIC CELL THERAPY FOR CANCER
Dendritic cells are cells of the immune system that help in the fight against cancer.
Denvax is your personalised cancer treatment that involves cancer-fighting dendritic cells. Being autologous, it is non-toxic and does not interfere with an ongoing treatment plan or the patient’s daily routine.
Denvax is a treatment for most solid tumours, including lymphoma and multiple myeloma. It can be given at any stage of the disease. It is targeted therapy and comes under the 4th modality of cancer treatment called cancer Immunotherapy. The other three are Surgery, Radiation and Chemotherapy.
DENVAX: HOW DOES IT WORK?
In cancer, the immune system fails as cells of the immune system fail to recognise the cancer cells. The immune system doesn’t “see” tumours as foreign or dangerous, and doesn’t mount a strong attack against them.
Another reason tumours may not stimulate an immune response is that cancer cells develop ways to escape the immune system.
A dendritic cell is a specialised cell that boosts immune responses in our body, by correcting the failure to recognise the cancer cell. The activated immune system then circulates throughout the body and destroys the cancer cells.
DENVAX USES
Denvax is an Adjuvant/Additional treatment plan. It helps to fight cancer by killing the cancer cells. It works by activating the immune system against cancer. Cancer is best treated by a multi-disciplinary approach. The other treatment modalities including surgery, radiation and chemotherapy also help to kill the cancer cells. Denvax adds to this arsenal of killing cancer. It helps to improve quality of life, prolong life and give better clinical outcomes.
Denvax has little or no conflict with other treatment modalities. Being autologous (self), it is almost non-toxic and does not interfere with the patient’s ongoing treatment plan or his/her daily routine. In stage IV patients, it works as palliative therapy, which helps in giving comfort to the patient.
METHOD OF DENVAX PREPARATION
In this technique, the patient’s own blood cells are taken and transformed into dendritic cells that are trained to fight cancer cells. These dendritic cells given back to the patient initiate a fight against the disease at the cellular level and help in stopping cancer.
The first dose manufactured is given to the patient on the 10th day of blood collection. Subsequent doses are administered at 2- weeks intervals.
HOW TO BEGIN DENVAX TREATMENT?
To begin Denvax treatment, the patient or the attendant is required to contact our office, preferably nearby the patient's location. The patient is then required to send his reports and a short video, explaining or showing his/her current clinical status.
The doctor evaluates the patient's clinical condition and may or may not advise Denvax, based on Eligibility Criteria. Patients willing to take Denvax treatment are required to fill and sign an Informed Consent Form. The logistics team then works on the collection of blood drawn from the patient’s home. They assign a trained technical staff to travel to the patient’s location for blood collection.
It takes 8 days to manufacture Denvax. The patient may choose to get the Denvax dose in the comforts of their home or visit any of the Denvax clinics for receiving the dose. Trained technical staff along with Denvax dose is sent to the patient's home for administration. The technical staff leaves the patient's home only after the dose is safely received by the patient. Further doses are administered the same way.
HOW SAFE IS DENVAX?
Denvax has negligible adverse effects or toxicity as compared to chemotherapy. Being an autologous treatment it is safe and has minimal side effects. Some patients may experience fever for a day or two after taking Denvax therapy.
